Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.84 |
| ▸ | PPARD | Q03181 | 5/20 | 0.84 |
| ▸ | PPARA | Q07869 | 5/20 | 0.84 |
| ▸ | F7 | P08709 | 5/20 | 0.84 |
| ▸ | F3 | P13726 | 5/20 | 0.84 |
| ▸ | TERT | O14746 | 3/20 | 0.84 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.84 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.84 |
| ▸ | FABP4 | P15090 | 3/20 | 0.84 |
| ▸ | TOP1 | P11387 | 3/20 | 0.84 |
| ▸ | MAPT | P10636 | 2/20 | 0.84 |
| ▸ | BLM | P54132 | 2/20 | 0.84 |
| ▸ | LMNA | P02545 | 2/20 | 0.84 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.84 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.84 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.84 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.84 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.84 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.84 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2855222 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2573063 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2574228 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2858103 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL552081 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL17048016 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL4303654 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL808536 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL10201666 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2574226 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250369986-A1 | APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS | The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University (CN) | 2025-12-04 | — | — | US | claimed |
| EP-4657069-A1 | APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS | The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University (CN) | 2025-12-03 | — | — | EP | claimed |
| CN-118961914-A | Application of N-aminophthalimide in analysis of unsaturated lipid and unsaturated lipid analysis method | 中国科学院化学研究所 | 2024-11-15 | — | — | CN | claimed |
| US-20230410977-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES | 2023-12-21 | — | — | US | claimed |
| CN-117192009-A | Discovery and application of biomarker for gout disease by downward flow of damp-heat | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2023-12-08 | — | — | CN | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-20260000768-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECH BSJPHARMA CO LTD (CN) | 2026-01-01 | — | — | US | disclosed |
| US-20250369986-A1 | APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS | The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University (CN) | 2025-12-04 | — | — | US | disclosed |
| EP-4657069-A1 | APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS | The First Affiliated Hospital of the Chinese People's Liberation Army Army Medical University (CN) | 2025-12-03 | — | — | EP | disclosed |
| EP-3304033-B1 | METHODS FOR ANALYZING A TISSUE SAMPLE | PURDUE RESEARCH FOUNDATION (US) | 2025-11-26 | — | — | EP | disclosed |
| US-20250345290-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | BEIJING BAISHIHEKANG PHARMACEUTICAL TECH BSJPHARMA CO LTD (CN) | 2025-11-13 | — | — | US | disclosed |
| US-20250334596-A1 | ISOTOPIC LABELS FOR QUANTITATIVE MASS SPECTROMETRY OF LIPID ISOMERS | TEXAS A & M UNIV SYS (US) | 2025-10-30 | — | — | US | disclosed |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | INSTITUTE OF BASIC MEDICAL SCIENCES (CN) | 2025-04-22 | — | — | US | disclosed |
| CN-117192009-A | Discovery and application of biomarker for gout disease by downward flow of damp-heat | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2023-12-08 | — | — | CN | disclosed |
| CN-111077308-B | Serum metabolism marker for tuberculosis drug resistance diagnosis and application thereof | 佛山市第四人民医院(佛山市结核病防治所) | 2023-07-04 | — | — | CN | disclosed |
| US-20220093380-A1 | METHODS FOR ANALYZING A TISSUE SAMPLE | NATIONAL SCIENCE FOUNDATION | 2022-03-24 | — | — | US | disclosed |
| CN-112305124-B | Biomarker and application thereof in disease diagnosis | 河北医科大学第二医院 | 2022-03-04 | — | — | CN | disclosed |
| WO-2015128428-A1 | PHEROMONE DISPENSER MADE OF PLASTIC MATERIAL | BASF SE (DE) | 2015-09-03 | — | — | WO | disclosed |
| EP-2384111-A1 | PHEROMONE DISPENSER | BASF SE (DE) | 2011-11-09 | — | — | EP | disclosed |
| WO-2010076316-A1 | PHEROMONE DISPENSER | BASF SE (DE) | 2010-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000768-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | FABP2, NSUN2, TRDMT1 | PPARG 2023/4885PPARD 4264/4885PPARA 2755/4885 |
| US-20250345290-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | TRDMT1, HNRNPAB, HNRNPA1 | PPARG 592/4885PPARD 2109/4885PPARA 1353/4885 |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | CHMP4B, FIP1L1, LIPC | PPARG 2284/4885PPARD 3004/4885PPARA 2881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.